Jawbone sues Fitbit over patent infringement, its second suit against Fitbit in two weeks
Jawbone Hits Fitbit With Second Lawsuit in Two Weeks — Fitness trackers from Jawbone and Fitbit are made to count heartbeats. They may soon be put to use counting lawsuits between the two rivals.
Context & Ripple Effects
This is round two of a multi-front campaign: two weeks after [[a:829588|accusing Fitbit of systematically plundering confidential information through poached employees]], Jawbone adds a patent-infringement claim to the trade-secret fight. Two suits inside a fortnight signals deliberate strategy rather than legal opportunism — Jawbone is attacking the market leader on every legal axis available.
The stakes are asymmetric. Fitbit holds the consumer traction in fitness trackers while Jawbone trails, so Jawbone is converting the courtroom into its competitive arena — a playbook that escalates a month later when it asks regulators, not just judges, for relief.
First-order effects
- Fitbit must defend on two simultaneous fronts — trade-secret theft and now patent infringement — multiplying legal costs and executive distraction while it leads the tracker market.
- Jawbone gains a second pressure lever beyond damages: if its patent claims hold, they become bargaining chips over Fitbit's core product line.
Second-order effects
- Escalation moves from damages to market access: within a month Jawbone files an ITC complaint seeking to block Fitbit from importing fitness trackers into the US altogether.
- Fitbit answers in kind with patent claims of its own, prompting the countersuit Jawbone publicly brands "frivolous" — locking both companies into years of mutual litigation spend neither can easily exit.
Third-order effects
- When hardware margins are thin, litigation substitutes for product differentiation — and the pattern shows its limits, as an ITC judge later rules the Jawbone patents invalid and Fitbit eventually stops seeking sales blocks entirely.
- If the template holds, trade-secret and patent suits become the standard opening move for hardware challengers losing share, with the ITC import-ban lever making US market access itself part of competitive strategy — until weaker IP consolidates the field under larger platforms, as Fitbit's eventual absorption into Google's health stack suggests.
The trend: Consumer-hardware rivalry is migrating from the retail shelf to the courtroom and the ITC, with patent suits serving as proxy weapons wherever product differentiation stalls.